Biogen didn't have much success on the market with multiple sclerosis med Zinbryta, and now the drug is at the center of a discrimination and retaliation lawsuit by a former manager.
Former senior territorial business manager Danita Erickson sued Biogen July 13 in Washington, saying concerns she shared about off-label promotion of the med ended in her firing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,